7th Annual Stem Cell Research & Therapeutic Conference
http://www.gtcbio.com/component/conference...peutics=&cid=22
May 26-27, 2011 - Boston, Massachusetts, USA

Dear Colleagues,

Hematopoietic stem cells are derived during embryogenesis, and can self-renew or differentiation into the peripheral blood lineages. During development, tissues are induced to express hematopoietic transcription factors in specific regions of the embryo. Utilizing the zebrafish as a model system, signaling pathways have been found that are critical for the blood stem cell formation, and these pathways are also used for stem cell self-renewal in adults. Studies of embryos have thus provided invaluable information on the pathways that regulate hematopoietic stem cells.

Dr. Leonard Zon will give a keynote presentation at GTCbio's 7th Stem Cell Research & Therapeutics Conference to be held in Boston, MA on May 26-27, 2011. Dr. Zon is internationally recognized for his pioneering work in the fields of stem cell biology and cancer genetics. He is founder and former president of ISSCR and chair of the Executive Committee of the newly formed Harvard Stem Cell Institute (HSCI). Dr. Zon will give a presentation entitled "Chemicals that Regulate Blood Stem Cell Self-Renewal and Differentiation" and will give an understanding of blood development, provide insight to new drugs for marrow transplantation, show advances in leukemia treatment and discuss the study of self-renewal of blood stem cells.

Come meet and network with leaders in stem cell research at GTCbio`s Stem Cell Research & Therapeutics Conference in Boston. Join in the discussion with colleagues in academia and industry to share and learn about the latest research technologies and novel discoveries in the area of stem cells. Gain insight into the issues and challenges facing the research community and hear success stories from industry leaders. Sign up now as space is limited to ensure optimal networking. Register now to save up to $300! Or Register 2, the 3rd person goes free. Click here to send your team!

CONFERENCE SESSIONS:

Sessions for the conference include:
. Induced Pluripotent Stem Cells, Reprogramming and Regulation
. Maintaining Memory - advantages/disadvantages
. miRNA regulation in IPS and hES cells
. Direct Conversion and Other Novel Technologies in Stem Cell Research
. Cancer Stem Cells
. Regulatory Aspects, Commercialization & Funding Opportunities
. Advances in Regenerative Medicine and Tissue Engineering
. Safety and Immunogenicity
. Tumorgenicity - Teratoma issue
. Immunogenicity of iPS cell driven derivatives
. Bringing Research to Drug Discovery
. Identifying phenotypes representative of disease
. Successes in translation
. Technology to increase scale and quality for screening